
News|Articles|August 1, 2006
Pipeline Preview (August 2006)
Hepatitis B immune globulin (human) (Nabi-HB, Nabi Bio-pharmaceuticals) for the treatment of hepatitis B infection
Advertisement
Recommendations for approval
Approvable designations
Fast-track designations
Orphan drug designations
Non-approvable designations
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Gilead’s Single-Tablet HIV Regimen Meets Primary Endpoints
2
COVID-19 vaccines could help tumors respond better to immune checkpoint inhibitors
3
Keytruda shows survival edge over Tecentriq, Opdivo in older patients with lung cancer
4
Integrin beta-6 emerges as a novel biomarker for NSCLC
5


















































